Patents by Inventor Alexis Denis

Alexis Denis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8722746
    Abstract: The invention relates to hydroxyphenyl derivatives of formula (I); and uses thereof as anti-bacterial and/or anti-parasitic agents.
    Type: Grant
    Filed: April 16, 2007
    Date of Patent: May 13, 2014
    Assignee: Fab Pharma S.A.S.
    Inventors: Alexis Denis, Vincent Gerusz, Yannick Bonvin
  • Patent number: 8513250
    Abstract: The invention relates to Imidazolo-heteroaryl derivatives of formula (I). The compounds inhibit the activity of the Dlta enzyme of Gram-positive bacteria and are useful to treat Gram-positive bacterial infections. Furthermore the application discloses method for assessing the Dlta inhibitory activity of tested molecules and a method for measuring the efficacy of molecules in inhibiting bacteria proliferation in vitro.
    Type: Grant
    Filed: March 21, 2008
    Date of Patent: August 20, 2013
    Assignee: Laboratoire Biodim
    Inventors: Sonia Escaich, Alexis Denis, Vincent Gerusz, François Moreau, Mayalen Oxoby, Yannick Bonvin
  • Publication number: 20120277207
    Abstract: The invention relates to novel heterocyclic acrylamide compounds (I), to the preparation of the compounds and intermediates used therein, to the use of the compounds as antibacterial medicaments and pharmaceutical compositions containing the compounds.
    Type: Application
    Filed: November 17, 2010
    Publication date: November 1, 2012
    Inventors: Vincent Gerusz, Sonia Escaich, Mayalen Oxoby, Alexis Denis
  • Publication number: 20120232155
    Abstract: The invention relates to a novel hydroxyphenyl compound, to the preparation of the compound and intermediates used therein, to the use of the compound as an antibacterial medicament and pharmaceutical compositions containing the compound.
    Type: Application
    Filed: November 11, 2009
    Publication date: September 13, 2012
    Inventors: Vincent Gerusz, Fabien Faivre, Mayalen Oxoby, Alexis Denis, Yannick Bonvin
  • Patent number: 8217075
    Abstract: 2-amino-2-phenyl-alkanol ester derivatives of general formula (I) in which: R1 is H, straight or branched 1 to 4C alkyl, straight or branched 2 to 4C alkyl substituted by OH, alkoxy, alkylthio, acyloxy, NH2, alkylamino, dialkylamino, alkylcarbamoyloxy, alkoxycarbonylamino, ureido or alkylureido, R2 is a —CO—R radical in which R is H, alkyl, aryl, heterocyclyl, benzyl or heterocyclylmethyl, or R2 is a —CO—Y—R4 radical for which Y is —O—, —S—, —NH—, -Nalk- for which alk is straight or branched (1 to 4C) alkyl, and R4 is alkyl, aryl, aralkyl or heterocyclylalkyl, capable of being substituted by one or more halogen atoms or OH radicals, straight or branched (1 to 4C) alkyl, alkoxy, alkylthio, acylaminoalkylthio, alkoxycarbonyl or acylamino (1 to 4C) straight or branched, or oxo, or capable of being substituted by R5COO— in which R5 is alkyl optionally substituted by benzyloxycarbonylamino, acylamino or by an amino acid residue, or represents an heterocyclyl radical, or R2 is alkyl (2 to 4C) substituted by OH, alk
    Type: Grant
    Filed: January 27, 2009
    Date of Patent: July 10, 2012
    Assignee: Oroxcell
    Inventors: Jean Pachot, Christophe Dini, Alexis Denis
  • Publication number: 20100130489
    Abstract: The invention relates to Imidazolo-heteroaryl derivatives of formula (I). The compounds inhibit the activity of the Dlta enzyme of Gram-positive bacteria and are useful to treat Gram-positive bacterial infections. Furthermore the application discloses method for assessing the Dlta inhibitory activity of tested molecules and a method for measuring the efficacy of molecules in inhibiting bacteria proliferation in vitro.
    Type: Application
    Filed: March 21, 2008
    Publication date: May 27, 2010
    Applicant: MUTABILIS SA
    Inventors: Sonia Escaich, Alexis Denis, Vincent Gerusz, Francois Moreau, Mayalen Oxoby, Yannick Bonvin
  • Publication number: 20100041658
    Abstract: The invention relates to hydroxyphenyl derivatives of formula (I); and uses thereof as anti-bacterial and/or anti-parasitic agents.
    Type: Application
    Filed: April 16, 2007
    Publication date: February 18, 2010
    Inventors: Alexis Denis, Vincent Gerusz, Yannick Bonvin
  • Publication number: 20100022541
    Abstract: The invention relates to new compounds having heptose synthesis inhibitory properties, of formula (I) or a pharmaceutically acceptable salt, or prodrug thereof, wherein A is an aryl or heterocycle, optionally substituted by one or several identical or different R such as H, C1-C10 alkyl, C1-C10 alkyl-OR1, C1-C10 alkyl-NR1R1, alkoxy, hydroxy, thioalkyl, aryl, heterocycle, halogen, nitro, cyano, CO2R1, NR1R1, NR1C(O)R1, C(O)NR1R1, NR1C(S)R1, C(S)NR1R1, SO2NR1R1, SO2R1, NR1SO2R1, NR1C(O)NR1R1, NR1C(O)OR1, NR1C(S)NR1R1, NR1C(S)OR1, R1C?NOR1, C(O)R1, aryloxy, thioaryl, alkenyl, alkynyl R1 identical or different is H or C1-C10 alkyl B1, B2, B3 identical or not represent C, N, O, S to form a five-membered aromatic ring wherein from one to three carbon atoms are replaced by a heteroatom selected from S, O, N optionally substituted by one or several identical or different R such as defined above B4 is C or N Y is H, C1-C10 alkyl, alkoxy, thio-alkyl, optionally substituted by one or several identical or different R suc
    Type: Application
    Filed: September 25, 2007
    Publication date: January 28, 2010
    Inventors: Sonia Escaich, Alexis Denis, Francois Moreau, Vincent Gerusz, Nicolas Desroy
  • Publication number: 20090197924
    Abstract: 2-amino-2-phenyl-alkanol ester derivatives of general formula (I) in which: R1 is H, straight or branched 1 to 4C alkyl, straight or branched 2 to 4C alkyl substituted by OH, alkoxy, alkylthio, acyloxy, NH2, alkylamino, dialkylamino, alkylcarbamoyloxy, alkoxycarbonylamino, ureido or alkylureido, R2 is a —CO—R radical in which R is H, alkyl, aryl, heterocyclyl, benzyl or heterocyclylmethyl, or R2 is a —CO—Y—R4 radical for which Y is —O—, —S—, —NH—, -Nalk- for which alk is straight or branched (1 to 4C) alkyl, and R4 is alkyl, aryl, aralkyl or heterocyclylalkyl, capable of being substituted by one or more halogen atoms or OH radicals, straight or branched (1 to 4C) alkyl, alkoxy, alkylthio, acylaminoalkylthio, alkoxycarbonyl or acylamino (1 to 4C) straight or branched, or oxo, or capable of being substituted by R5COO— in which R5 is alkyl optionally substituted by benzyloxycarbonylamino, acylamino or by an amino acid residue, or represents an heterocyclyl radical, or R2 is alkyl (2 to 4C) substituted by OH, alk
    Type: Application
    Filed: January 27, 2009
    Publication date: August 6, 2009
    Applicants: Oroxcell, Alexis Denis
    Inventors: Jean Pachot, Christophe Dini, Alexis Denis
  • Patent number: 7456164
    Abstract: The invention relates to 3- or 4-monosubstituted phenol and thiophenol derivatives of formula (I) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. Said 3- or 4-monosubstituted phenol and thiophenol derivatives are H3 ligands and are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Grant
    Filed: May 9, 2005
    Date of Patent: November 25, 2008
    Assignee: Pfizer, Inc
    Inventors: Patrick Bernardelli, Andrew Michael Cronin, Alexis Denis, Stephen Martin Denton, Henry Jacobelli, Mark Ian Kemp, Edwige Lorthiois, Fiona Rousseau, Delphine Serradeil-Civit, Fabrice Vergne
  • Patent number: 7119180
    Abstract: A subject of the invention is a process for the preparation of the compounds of formula (I): Wherein the substituents are defined as in the application. The compounds of this invention exhibit antibiotic properties.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: October 10, 2006
    Assignee: Aventis Pharma S.A.
    Inventors: Constantin Agouridas, Francois Bretin, Alexis Denis, Claude Fromentin
  • Publication number: 20050267095
    Abstract: The invention relates to 3- or 4-monosubstituted phenol and thiophenol derivatives of formula (I) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. Said 3- or 4-monosubstituted phenol and thiophenol derivatives are H3 ligands and are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Application
    Filed: May 9, 2005
    Publication date: December 1, 2005
    Inventors: Patrick Bernardelli, Andrew Cronin, Alexis Denis, Stephen Denton, Henry Jacobelli, Mark Kemp, Edwige Lorthiois, Fiona Rousseau, Delphine Serradeil-Civit, Fabrice Vergne
  • Publication number: 20050065101
    Abstract: A subject of the invention is a process for the preparation of the compounds of formula (I): Wherein the substituents are defined as in the application. The compounds of this invention exhibit antibiotic properties.
    Type: Application
    Filed: November 12, 2004
    Publication date: March 24, 2005
    Applicant: Aventis Pharma S.A.
    Inventors: Constantin Agouridas, Francois Bretin, Alexis Denis, Claude Fromentin
  • Publication number: 20050014816
    Abstract: The invention provides compounds of Formula (I), stereoisomers thereof, or pharmaceutically acceptable salts of said compounds or stereoisomers, wherein R1, R2, m, p, q, R7 and R8 are as defined below, as well as compositions comprising the same, processes for making the same, and methods of using the same to treat a variety of diseases, including, those requiring interaction with metalloproteases, and more specifically with macrophage metalloelastase (MMP-12), and for the prevention and treatment of respiratory pathologies such as chronic obstructive bronchopneumopathy (COPD), emphysema, chronic bronchitis, chronic pulmonary inflammation, asthma, cystic fibrosis, acute respiratory distress syndrome (ARDS), respiratory allergies including allergic rhinitis, and also diseases associated with the production of TNF? including severe fibrotic pulmonary disease, pulmonary sarcoidosis and silicosis.
    Type: Application
    Filed: July 2, 2004
    Publication date: January 20, 2005
    Inventors: Delphine Compere, Anne-Claude Dublanchet, Karine Courte, Stephane Blais, Pierre Ducrot, Philippe Cluzeau, Alexis Denis
  • Publication number: 20040072871
    Abstract: A compound of formula (I) selected from: 1
    Type: Application
    Filed: August 8, 2003
    Publication date: April 15, 2004
    Inventors: Anne-Claude Dublanchet, Delphine Compere, Philippe Cluzeau, Stephane Blais, Alexis Denis, Pierre Ducrot, Karine Courte, Sophie Descamps
  • Patent number: 6706692
    Abstract: The invention concerns compounds of formula (I) wherein: X represents a (NH)a, CH2 or SO2 radical or an oxygen atom; a represents 0 or 1; Y represents a (CH2)m-(CH═CH)n-(CH2)o radical with m+n+o≦8, n=0 or 1; Ar represents an aryl or heteroaryl radical, optionally substituted; W represents a hydrogen atom or a halogen atom; Z represents a hydrogen atom or an acid residue, and their addition salts with acids.
    Type: Grant
    Filed: April 10, 2001
    Date of Patent: March 16, 2004
    Assignee: Aventis Pharma S.A.
    Inventors: Jean-Michel Auger, Alexis Denis
  • Patent number: 6664398
    Abstract: A subject of the invention is the compounds of formula in which Y represents a hydrogen atom or a fluorine atom, n represents an integer comprised between 1 and 8, Z represents a hydrogen atom or the remainder of a carboxylic acid, optionally substituted on the heterocycle by one or more alkyl, alkenyl, alkynyl, O-alkyl, O-alkenyl, O-alkynyl, S-alkyl, S-alkenyl, S-alkynyl radicals containing up to 8 carbon atoms, one or more OH, NH2, C═N, NO2, CF3 radicals or one or more aryl radicals containing up to 14 carbon atoms or heteroaryl radicals containing one or more nitrogen oxygen or sulphur atoms, the aryl or heteroaryl radicals themselves being able to be substituted as well as their addition salts with acids, The products of formula (I) have antibiotic properties.
    Type: Grant
    Filed: July 2, 2002
    Date of Patent: December 16, 2003
    Assignee: Aventis Pharma S.A.
    Inventor: Alexis Denis
  • Publication number: 20030050254
    Abstract: A subject of the invention is the compounds of formula 1
    Type: Application
    Filed: July 2, 2002
    Publication date: March 13, 2003
    Applicant: Hoechst Marion Roussel
    Inventor: Alexis Denis
  • Patent number: 6455505
    Abstract: A subject of the invention is, as new chemical products, the compounds of formula (I) in which X represents a hydrogen atom or a halogen atom and Z represents a hydrogen atom or the remainder of an acid as well as their addition salts with acids. The compounds of formula (I) have antibiotic properties.
    Type: Grant
    Filed: November 3, 1999
    Date of Patent: September 24, 2002
    Assignee: Hoechst Marion Roussel
    Inventors: Constantin Agouridas, Alexis Denis, Claude Fromentin
  • Patent number: RE39743
    Abstract: Novel compounds of the formula wherein the substituents are defined as in the application having antibiotic properties.
    Type: Grant
    Filed: November 21, 2002
    Date of Patent: July 24, 2007
    Assignee: Aventis Pharma S.A.
    Inventors: Constantin Agouridas, Francois Bretin, Alexis Denis, Claude Fromentin